About oncidiumfoundation_brbf8h

This author has not yet filled in any details.
So far oncidiumfoundation_brbf8h has created 57 blog entries.

Lu-177-Lilotomab Satetraxetan (Betalutin)

Betalutin™ is the brand name of an anti-CD37 antibody labeled [...]

Lu-177-TLX250

177Lu-TLX250 (177Lu-Lutarex®, 177Lu-Girentuximab), a Lutetium-177-labeled monoclonal antibody is being developed [...]

Lu-177-Edotreotide (Solucin®)

177Lu-Edotreotide (177Lu--Octreotide, 177Lu-Solucin®) is a radiolabeled somatostatin analogue developed [...]

Lu-177-IPN-01087

177Lu-IPN-01087 (177Lu-3BP-227) is a neurotensin antagonist peptide labeled with 177Lu [...]

Ho-166-Phytate

166Ho-Phytate (Holmium-166-Phytate) was developed as an iv radiotherapeutic for the [...]

Sm-153-DOTMP (CycloSAM)

153Sm-DOTMP (153Sm-CycloSAM) is a bone pain palliation agent under [...]

I-131-TM601

131I-TM601 (131I-Chlorotoxin) is a synthetic radiolabeled peptide with anti-angiogenic activity [...]

I-131-CLR 131

131I-CLR 131 (131I-CLR-1404, 131I-NM404) is a small molecule, an alkyl [...]

I-131-Apamistamab (Iomab-B™)

131I-Apamistamab (131I-BC8, Iomab-B™) is an anti-CD45 radioimmunotherapy for the [...]

Re-188-Etidronate (HEDP)

188Re-Etidronate (188Re-HEDP) is a therapeutic agent for bone metastases treatment. [...]

Go to Top